Back to RGNX

MARSHALL WACE, LLP → RGNX

MARSHALL WACE, LLP RGNX Position History

REGENXBIO Inc. • Healthcare

Quarters held
9
Latest value
$6.2M
Q3 2026
Peak value
$15.1M
First seen
Q3 2023

Dollar value over time

Show data table
PeriodPosition value
Q3 2023$547K
Q2 2024$457K
Q1 2025$36K
Q1 2025$1.6M
Q2 2025$1.8M
Q2 2026$339K
Q2 2026$15.1M
Q3 2026$457K
Q3 2026$6.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$6.2M817.9K——
Q3 2026$457K60.7K——
Q2 2026$15.1M1.26M——
Q2 2026$339K28.3K——
Q2 2025$1.8M222.3K——
Q1 2025$1.6M220.5K——
Q1 2025$36K5.0K——
Q2 2024$457K39.1K——
Q3 2023$547K33.2K——

Other funds holding RGNX

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B